[1]
|
Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
孙可欣, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11.
|
[3]
|
Zhang, Y., Chen, Z. and Li, J. (2017) The Current Status of Treatment for Colorectal Cancer in China: A Systematic Review. Medicine, 96, e8242. https://doi.org/10.1097/MD.0000000000008242
|
[4]
|
Van Cutsem, E., Cervantes, A., Nordlinger, B. and Arnold, D. (2014) Metastatic Colorectal Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Annals of Oncology, 25, iii1-iii9.
https://doi.org/10.1093/annonc/mdu260
|
[5]
|
Duffy, M.J., et al. (2014) Tumor Markers in Colorectal Cancer, Gas-tric Cancer and Gastrointestinal Stromal Cancers: European Group on Tumor Markers 2014 Guidelines Update. Interna-tional Journal of Cancer, 134, 2513-2522.
https://doi.org/10.1002/ijc.28384
|
[6]
|
Silsirivanit, A. (2019) Chapter Five-Glycosylation Markers in Cancer. In: Makowski, G.S., Ed., Advances in Clinical Chemistry, 89, Academic Press, Cambridge, 189-213. https://doi.org/10.1016/bs.acc.2018.12.005
|
[7]
|
Gold, P. and Freedman, S.O. (1965) Demonstration of Tu-mor-Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniques. Journal of Experimental Medicine, 121, 439-462.
https://doi.org/10.1084/jem.121.3.439
|
[8]
|
Gold, P. and Freedman, S.O. (1965) Specific Carcinoembryonic Anti-gens of the Human Digestive System. Journal of Experimental Medicine, 122, 467-481. https://doi.org/10.1084/jem.122.3.467
|
[9]
|
Beauchemin, N. and Arabzadeh, A. (2013) Carcinoembryonic Anti-gen-Related Cell Adhesion Molecules (CEACAMs) in Cancer Progression and Metastasis. Cancer and Metastasis Re-views, 32, 643-671.
https://doi.org/10.1007/s10555-013-9444-6
|
[10]
|
Rodrigues, J.G., et al. (2018) Glycosylation in Cancer: Selected Roles in Tumour Progression, Immune Modulation and Metastasis. Cellular Immunology, 333, 46-57. https://doi.org/10.1016/j.cellimm.2018.03.007
|
[11]
|
Rückert, F., Pilarsky, C. and Grützmann, R. (2010) Serum Tu-mor Markers in Pancreatic Cancer-Recent Discoveries. Cancers, 2, 1107-1124. https://doi.org/10.3390/cancers2021107
|
[12]
|
Sousa, A.R., Oliveira, M.J. and Sarmento, B. (2019) Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer. Journal of Pharmacology and Experimental Ther-apeutics, 370, 657-670.
https://doi.org/10.1124/jpet.118.254441
|
[13]
|
Hammarström, S. (1999) The Carcinoembryonic Antigen (CEA) Family: Structures, Suggested Functions and Expression in Normal and Malignant Tissues. Seminars in Cancer Biology, 9, 67-81. https://doi.org/10.1006/scbi.1998.0119
|
[14]
|
Tiernan, J.P., et al. (2013) Carcinoembryonic Antigen Is the Preferred Biomarker for in Vivo Colorectal Cancer Targeting. British Journal of Cancer, 108, 662-667. https://doi.org/10.1038/bjc.2012.605
|
[15]
|
Lee, J.S., et al. (2013) Elevated Levels of Preoperative CA 15-3 and CEA Serum Levels Have Independently Poor Prognostic Significance in Breast Cancer. Annals of Oncology, 24, 1225-1231.
https://doi.org/10.1093/annonc/mds604
|
[16]
|
Feng, F., et al. (2017) Diagnostic and Prognostic Value of CEA, CA19-9, AFP and CA125 for Early Gastric Cancer. BMC Cancer, 17, Article No. 737. https://doi.org/10.1186/s12885-017-3738-y
|
[17]
|
Grunnet, M. and Sorensen, J.B. (2012) Carcinoembryonic Anti-gen (CEA) as Tumor Marker in Lung Cancer. Lung Cancer, 76, 138-143. https://doi.org/10.1016/j.lungcan.2011.11.012
|
[18]
|
Lee, K J., et al. (2013) Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma. Yonsei Medical Journal, 54, 643-649. https://doi.org/10.3349/ymj.2013.54.3.643
|
[19]
|
Stockley, R.A., et al. (1986) Effect of Cigarette Smoking, Pulmo-nary Inflammation, and Lung Disease on Concentrations of Carcinoembryonic Antigen in Serum and Secretions. Thorax, 41, 17-24. https://doi.org/10.1136/thx.41.1.17
|
[20]
|
Kashiwabara, K., Nakamura, H. and Yokoi, T. (2001) Chrono-logical Change of serum Carcinoembryonic Antigen (CEA) Concentrations and Pulmonary Function Data after Cessation of Smoking in Subjects with Smoking-Associated CEA Abnormality. Clinica Chimica Acta, 303, 25-32. https://doi.org/10.1016/S0009-8981(00)00341-7
|
[21]
|
Fahy, B.N. (2014) Follow-up after Curative Resection of Colorectal Cancer. Annals of Surgical Oncology, 21, 738-746.
https://doi.org/10.1245/s10434-013-3255-4
|
[22]
|
Tsikitis, V.L., et al. (2009) Postoperative Surveillance Recom-mendations for Early Stage Colon Cancer Based on Results from the Clinical Outcomes of Surgical Therapy Trial. Jour-nal of Clinical Oncology, 27, 3671-3676.
https://doi.org/10.1200/JCO.2008.20.7050
|
[23]
|
Goldstein, M.J. and Mitchell, E.P. (2005) Carcinoembryonic Anti-gen in the Staging and Follow-up of Patients with Colorectal Cancer. Cancer Investigation, 23, 338-351. https://doi.org/10.1081/CNV-58878
|
[24]
|
Compton, C., Fenoglio-Preiser, C.M., Pettigrew, N. and Fielding, L.P. (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer, 88, 1739-1757.
https://doi.org/10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T
|
[25]
|
鞠鹏飞. 血清肿瘤标记物对结直肠癌腹膜转移预判的研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2020.
|
[26]
|
Saito, G., et al. (2017) Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence. Oncology, 92, 276-282. https://doi.org/10.1159/000456075
|
[27]
|
武天同. CEA、CA19-9和CA72-4联检在结直肠癌预后中的临床研究[D]: [硕士学位论文]. 广州: 南方医科大学, 2018.
|
[28]
|
石方玉. Ki67、EGFR、P53及血清肿瘤标记物CEA、CA199对结直肠癌预后的价值分析[D]: [硕士学位论文]. 承德: 承德医学院, 2022.
|
[29]
|
王文军, 杨伏猛, 刘倩. D二聚体和肿瘤标志物与结直肠癌的相关性研究[J]. 中国继续医学教育, 2018, 10(2): 55-56.
|
[30]
|
蔡丽彬. 血浆循环游离DNA与CEA在结直肠癌中的临床研究[D]: [硕士学位论文]. 苏州: 苏州大学, 2018.
|
[31]
|
邓子昂, 李洋, 杨作磊, 冉锐. 血浆Septin9甲基化和血清CEA联合检测在结直肠癌诊断中的临床意义[J]. 现代医药卫生, 2020, 36(11): 1628-1630+1633.
|
[32]
|
龙华婧, 邱芳华, 刘道利, 刘燕娣, 周意, 吴嘉怡. 血清肿瘤标记物与多层螺旋CT、肠镜及病理联合检查对结直肠癌的诊断价值[J]. 国际检验医学杂志, 2019, 40(15): 1802-1806+1810.
|
[33]
|
Kantor, J., et al. (1992) Immunogenicity and Safety of a Recombinant Vaccinia Virus Vaccine Expressing the Carcinoembryonic Antigen Gene in a Nonhuman Primate. Cancer Research, 52, 6917-6925.
|
[34]
|
Hance, K.W., Zeytin, H.E. and Greiner, J.W. (2005) Mouse Models Expressing Human Carcinoembryonic Antigen (CEA) as a Transgene: Evaluation of CEA-Based Cancer Vaccines. Mutation Research, 576, 132-154.
https://doi.org/10.1016/j.mrfmmm.2004.10.014
|
[35]
|
Bei, R. and Scardino, A. (2010) TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy. BioMed Research International, 2010, Article ID: 102758. https://doi.org/10.1155/2010/102758
|
[36]
|
Marshall, J.L., et al. (2000) Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonrepli-cating Avipox Virus to Elicit Anti-Carcinoembryonic Antigen Immune Responses. Journal of Clinical Oncology, 18, 3964-3973.
https://doi.org/10.1200/JCO.2000.18.23.3964
|
[37]
|
Conry, R.M., et al. (2000) Human Autoantibodies to Carci-noembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine. Clinical Cancer Research, 6, 34-41.
|
[38]
|
von Mehren, M., et al. (2001) The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma. Clinical Can-cer Research, 7, 1181-1191.
|
[39]
|
Zeytin, H.E., et al. (2004) Combination of a Poxvirus-Based Vaccine with a Cy-clooxygenase-2 Inhibitor (Celecoxib) Elicits Antitumor Immunity and Long-Term Survival in CEA.Tg/MIN Mice. Can-cer Research, 64, 3668-3678.
https://doi.org/10.1158/0008-5472.CAN-03-3878
|
[40]
|
Oun, R., Moussa, Y.E. and Wheate, N.J. (2018) The Side Effects of Platinum-Based Chemotherapy Drugs: A Review for Chemists. Dalton Transactions, 47, 6645-6653. https://doi.org/10.1039/C8DT00838H
|
[41]
|
Dinarvand, R., Sepehri, N., Manoochehri, S., Rouhani, H. and Atyabi, F. (2011) Polylactide-Co-Glycolide Nanoparticles for Controlled Delivery of Anticancer agents. International Journal of Nanomedicine, 6, 877-895.
https://doi.org/10.2147/IJN.S18905
|
[42]
|
Perkins, G.L., Slater, E.D., Sanders, G.K. and Prichard, J.G. (2003) Se-rum Tumor Markers. American Family Physician, 68, 1075-1082.
|
[43]
|
Murthy, S.K. (2007) Nanoparticles in Modern Medicine: State of the Art and Future Challenges. International Journal of Nanomedicine, 2, 129-141.
|
[44]
|
Pereira, I., Sousa, F., Kennedy, P. and Sarmento, B. (2018) Carcinoembryonic Antigen-Targeted Nanoparticles Potentiate the Deliv-ery of Anticancer Drugs to Colorectal Cancer Cells. International Journal of Pharmaceutics, 549, 397-403.
https://doi.org/10.1016/j.ijpharm.2018.08.016
|
[45]
|
Ji, X., Lv, H., Sun, X. and Ding, C. (2019) Green-Emitting Carbon Dot Loaded Silica Nanoparticles Coated with DNA-Cross-Linked Hydrogels for Sensitive Carcinoembryonic Antigen Detection and Effective Targeted Cancer Therapy. Chemical Communications, 55, 15101-15104. https://doi.org/10.1039/C9CC07831B
|
[46]
|
Boogerd, L.S.F., et al. (2018) Safety and Effectiveness of SGM-101, a Fluorescent Antibody Targeting Carcinoembryonic Antigen, for Intraoperative Detection of Colorectal Cancer: A Dose-Escalation Pilot Study. The Lancet Gastroenterology and Hepatology, 3, 181-191. https://doi.org/10.1016/S2468-1253(17)30395-3
|
[47]
|
de Valk, K.S., et al. (2021) Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer. Annals of Surgical Oncology, 28, 1832-1844.
https://doi.org/10.1245/s10434-020-09069-2
|